Facial Affect Sensitivity Training (FAST) for Mood Symptoms
Study Summary
This trial is testing a new intervention for children with elevated callous-unemotional traits. These traits are common in children who have conduct problems and can lead to poorer outcomes, even with well-established treatments. The new intervention, called FAST, is designed to improve facial affect recognition, which is thought to be linked to callous-unemotional traits. The goal is to see if FAST can reduce callous-unemotional traits and improve behavioral outcomes.
- Mood Symptoms
- Empathy
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 4 Secondary · Reporting Duration: FER will be assessed in each phase (R61 & R33) of the study at pre-treatment (session 1), post-treatment (end of 5 weeks), and 3-month follow-up as well as approximately every other week during the 5-week intervention.
Trial Safety
Trial Design
4 Treatment Groups
Arm 2: R61 No-Treatment Control
1 of 4
Arm 4: R33 Active Control
1 of 4
Arm 1: R61 FAST
1 of 4
Arm 3: R33 FAST
1 of 4
Active Control
Experimental Treatment
168 Total Participants · 4 Treatment Groups
Primary Treatment: Facial Affect Sensitivity Training (FAST) · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 6 - 11 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What therapeutic objectives are being sought by this clinical trial?
"The primary goal of this trial is to evaluate the modification in Callous-Unemotional Traits over a five week period. Pre-treatment, post-treatment and 3 month follow up observations will be conducted, as well as periodic assessments during intervention. Other objectives include alteration in Clinical Global Impression score, reciprocal eye contact between parent and child (I Love You Task) and Event Related Potential signal via electroencephalography for early emotion processing of facial expressions." - Anonymous Online Contributor
Does the study include seniors aged 75 and above?
"To meet the prerequisites for inclusion in this research, participants must be between 6 and 11 years old." - Anonymous Online Contributor
Are there any opportunities to enroll in this clinical trial at present?
"Current information on clinicaltrials.gov indicates that this trial is actively searching for suitable candidates, since it was posted on February 15th 2021 and last revised a day later." - Anonymous Online Contributor
How many participants are involved in this clinical trial?
"Indeed, clinicaltrials.gov clearly states that this medical trial is presently recruiting patients to participate. The initial posting was made on February 15th 2021 and the details were last updated one day after on February 16th 2021. A total of 168 individuals need to be enlisted from a single site." - Anonymous Online Contributor
Is it possible for me to become involved in this clinical investigation?
"Eligibility requirements for this clinical trial stipulate that persons with alexithymia, aged 6-11 years old may apply. At present, 168 individuals are being recruited to participate in the study." - Anonymous Online Contributor